FDA Approves Marketing , That Cites Yogurt's Ability , to Reduce Diabetes Risk.
NBC reports that the Food and Drug Administration
has decided that food makers can advertise
that regularly consuming yogurt could
reduce the risk of Type 2 diabetes.
NBC reports that the Food and Drug Administration
has decided that food makers can advertise
that regularly consuming yogurt could
reduce the risk of Type 2 diabetes.
The decision comes following a 2018 petition from
Danone North America, which owns major yogurt
brands Dannon, Activia, Wallaby Organic and Silk. .
The decision comes following a 2018 petition from
Danone North America, which owns major yogurt
brands Dannon, Activia, Wallaby Organic and Silk. .
The petition sought to have the FDA allow the
company to market yogurt's ability to reduce
the risk of Type 2 diabetes without objection.
On March 1, the FDA confirmed that
it would not oppose the marketing
campaign, while including some caveats. .
Those caveats include that the marketing must
note that evidence is limited to eating two cups,
equal to three servings, of yogurt per week. .
NBC reports that Danone's petition is
part of a standard process which the
FDA calls "qualified health claims.".
While these claims do not require the FDA's
approval, companies often petition the
agency to define the specific language
necessary to avoid making false claims.
The petition reportedly cited yogurt's nutrient
profile of proteins, vitamins and low sodium.
The petition also cited studies which have supported
the link between regularly consuming yogurt and
reduced risk of diabetes and related conditions.
The petition also noted that
the evidence supports the health
effects of yogurt as a food rather
than related to any single nutrient
or compound and thus is
independent of fat or sugar content. , FDA announcement, via NBC